Severe Outcome of Pharyngeal-Cervical-Brachial Pure Motor Axonal Neuropathy by Bonanni, L. et al.
  The Open Neurology Journal, 2010, 4, 1-4 1 
 
  1874-205X/10  2010 Bentham Open 
Open Access 
Severe Outcome of Pharyngeal-Cervical-Brachial Pure Motor Axonal 
Neuropathy 
L. Bonanni*
,1, V. Onofrj
2, V. Scorrano
3, M. Onofrj
1 and A. Thomas
1 
1Department of Neurology, University G.D’Annunzio of Chieti-Pescara and Aging Research Center, Ce.S.I., “Gabriele 
d’Annunzio” University Foundation, Italy 
2University Ospedale San Raffaele, Milan, Italy 
3Neurofisiopatologia, Ospedale Civile di Pescara, Italy 
Abstract: We present two further cases of the pharyngeal-cervical-brachial (PCB) form of GBS, with unfavourable out-
come, showing dramatic dissociation between upper and lower body Symptoms. 
Both patients showed rapidly progressive motor denervation with disappearance of Compound Muscle Action Potentials 
(CMAPs) in upper limbs muscles. Sensory Nerve Action Potentials (SNAPs) were instead normal. Normal reflexes, F 
waves and action potentials were elicited in lower limbs. Despite i.v. Immunoglobulin treatment no recovery was ob-
served and both patients died within a year from onset of symptoms. 
INTRODUCTION 
  Guillain-Barré Syndrome(GBS) is probably an autoim-
mune disorder with peripheral nerve involvement [1] charac-
terized in its usual presentation by widespread muscle weak-
ness with areflexia, ascending from lower limbs(Landry’s 
Ascending Paralysis) [2]. 
  However, GBS includes variants presenting with focal 
signs and symptoms [3,4] and prominently axonal or demye-
linating forms [5]. 
  Among them, a pharyngeal-cervical-brachial (PCB) form 
was described by Ropper in 1986 [6] who described three 
cases of pharyngeal-cervical-brachial weakness. Preservation 
of power and reflexes and normal electrophysiological pa-
rameters in the lower limbs are common features of PCB 
eventhough mild weakness of lower limbs may be present 
[6]. 
  We present two cases of PCB with severely unfavourable 
evolution, with pure axonal motor degeneration. 
CASE REPORT 
 1.  A 72y.o. man was admitted to the hospital for the ap-
pearance, 15 days after an upper respiratory tract infection, 
of rhinolalia, difficulty in swallowing, upper limbs weak-
ness, rapidly progressing to dysarthria, severe dysphagia and 
respiratory deficit, making necessary tube feeding and as-
sisted ventilation. Body temperature was normal. Patient was 
wakeful and aware. Chest x-ray showed bilateral diaphrag-
matic paresis. Brain and cervical-spine MRI scan was nor-
mal. 
 
 
 
*Address correspondence to this author at the Department of Neurology, 
University G.D’Annunzio of Chieti-Pescara and Aging Research Center, 
Ce.S.I., “Gabriele d’Annunzio” University Foundation, Italy;  
E-mail: l.bonanni@unich.it 
  Eye movements and pupillary light reflex were normal. 
Sphincteric control was preserved but the patient was blad-
der catheterised as a routinal practice in critical care unit. 
Patient presented deficit of the eye-lid and lip closure. Mus-
cle strength (Medical Research Council scale) was 2 in the 
neck flexors, 1-2 in distal and 2-3 in proximal muscles of the 
upper limbs; strength was slightly impaired (4) in the left 
quadriceps [7] and normal in the right leg and feet. Patient 
was areflexic in upper limbs, tendon reflexes were normal in 
lower limbs. Pathological reflexes, sensory/vegetative dis-
turbances, lower limb ataxia were absent. 
  At day 7 from symptoms onset, muscle strength was 1 in 
the neck flexors, 0 in distal and 1 in proximal muscles of the 
upper limbs. No variation of strength was evidenced in lower 
limbs. At day 15 muscle strength was 0 in the neck flexor 
and the upper limbs were completely plegic (0 in proximal 
and distal muscles). 
  Laboratory tests including glucose, liver and muscle en-
zymes and electrolytes, seral protein levels were normal. 
Serum sampled on the day of admission showed no evidence 
of botulinum toxin (neutralization bioassay) or of anti-CMV. 
Anti-Campylobacter jejuni IgM and IgG (enzyme-linked 
immunosorbent assay, ELISA) were positive. Diphteria was 
excluded because patient had received vaccination and bacte-
rial cultures were negative. CSF examination at onset 
showed normal findings with no cells and normal protein 
level (25 mg/dl, upper normal limit 40 mg/dl) ; at day 15 
modest increase in protein level (55mg/dl) and no cells were 
detected. 
  We measured serum IgG antibodies to GT1a, GQ1b, 
GM1, GM1b, GM2, GD1a, GalNAc-GD1a, GD1b, and 
GT1b by ELISA. None of the antibodies tested was resulted 
positive. 
  At onset electrophysiology showed modest reduction of 
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conduction velocity, modest increment of the distal motor 
latency registered from hand muscles (4.5 ms median nerve, 
3.7 ms ulnar nerve, normal limits 5.0-2.5). F waves could not 
be regularly elicited from hand muscles; rare motor unit po-
tentials were recruited during voluntary activity; findings 
were normal in lower limbs; Sensory Nerve Action Poten-
tials (SNAPs) were normal in latency and amplitude in both 
upper and lower limbs. 
  At day 15 CMAPs could not be elicited in upper limbs or 
diaphragm. Spontaneous activity with fibrillation potentials 
and positive sharp waves (PSW) was diffusely present in 
upper limbs. Somatosensory evoked potentials(SSEPs) were 
normal. 
  Patient was treated with i.v. Immunoglobulin(2g/Kg) for 
2days, according to a widely accepted protocol [8] at day 2 
and at day 15 from symptom onset. 
  After one month from clinical onset, dysphagia, dysar-
trhia and upper limb weakness showed no recovery. Tendon 
reflexes were absent in upper limbs. Electrophysiology 
showed absent motor response to electrical stimulation with 
massive denervation in the upper limbs and diaphragm, no 
voluntary activity. No change in lower limbs and sensory 
components. 
  Six month after the onset the patient was stable with no 
further improvement of muscle weakness. He was still on 
assisted ventilation and tube feeding and was referred to a 
sub-intensive care unit. In the following year the patient died 
because of cardiopulmonary insufficiency following general-
ized sepsis. 
 2.  A 68y.o. man was admitted to our hospital for the ap-
pearance 10 days after a gastrointestinal infection of weak-
ness in both hands and dysarthria. MRI scan at admission 
was normal. After one day acute respiratory failure and 
dysphagia occurred requiring tracheotomy and tube feeding. 
Chest X-ray showed bilateral diaphragmatic paresis.  
  Eye and facial muscles movements were normal. 
Strength was 0 in right deltoid, 2 in the right biceps and tri-
ceps, 0 in the muscles of the left upper limb; normal in lower 
limbs. Tendon reflexes were absent in upper limbs, normal 
in lower limbs. No pathological reflexes, sensory/vegetative 
signs nor lower limb ataxia were present. Neurological ex-
amination after 2 weeks from treatment showed no im-
provement of symptoms. 
  CSF examination at admission showed normal protein 
level of 28mg/dl and 3 cells; at day 15 from clinical onset 
CSF showed 3 cells and protein levels of 64mg/dl.  
  Laboratory tests including glucose, liver and muscle en-
zymes and electrolytes, seral protein levels were normal. 
Diphteria was excluded because patient was vaccinated and 
bacterial cultures were negative. Botulinum toxin assay was 
negative. CMV serology was negative; Campylobacter jejuni 
IgM were positive. Low anti-GT1a IgG activity was found 
with negativity for anti-GD1a IgG and anti-GQ1b IgG. 
  Motor Nerve test at admission showed modest reduction 
of CMAP amplitude (0.9-1.7 V from hand muscles), slight 
increment of the distal motor latency in left median nerve 
(4.2 ms); normal conduction velocity and normal latency and 
amplitude of SNAPs in upper limbs. Voluntary activity elic-
ited sporadic MUAPs. Normal findings in lower limbs. 
  At day 15 electrophysiology showed absence of CMAP 
in upper limbs with inexcitability of all upper limb nerves 
and normal SNAPs, absence of voluntary activation, diffuse 
PSWs and fibrillation potentials in upper limb and dia-
phragm. Electrophysiological findings were normal in lower 
limbs. 
  SSEPs were normal. Patient was treated with i.v. Immu-
noglobulins at the dose of 2g/Kg/day for 2days at day 3 from 
symptoms onset and at day 15 with no improvement of 
symptoms. 
  After one month, neurological examination showed no 
recovery of bulbar palsy. Slight improvement of weakness in 
the right upper limb (1 in deltoid, 2 in biceps and triceps, 0 
in distal hand muscles). No improvement of left upper limb 
muscle strength, with inexcitability of all nerves tested and 
diffuse denervation of upper limb muscles. 
  At six months from the onset clinical and electrophysi-
ological signs were stable. Patient was on assisted ventilation 
in a sub-intensive care unit, he died after one year after an 
episode of pneumonia. 
  Patient caregivers signed an informed consent allowing 
us to videotape the patients. 
 Tables  1 and 2 summarize electrophysiological record-
ings in comparison with normative data for both patients. 
DISCUSSION 
  We presented two cases of pure motor PCB with very 
unfavourable outcome.  
  Bulbar palsy was the initial symptom as described by 
Ropper; involvement of upper limbs was subsequent. Lower 
limb strength and reflexes were spared with normal EMG 
parameters, SNAPs were normal, CMAPs in upper limbs 
completely disappeared in two weeks. Patients were on as-
sisted ventilation 6 months after the onset, despite i.v. Ig 
treatment. In both cases absent motor recovery led to fatal 
outcome. 
  In both patients, therefore, electrophysiological recording 
at onset and in the following weeks showed pure axonal mo-
tor neuropathy progressing to complete denervation of upper 
limb muscles and diaphragm, with electrical inexcitability of 
muscles, while SNAPs in upper limbs were normal through-
out follow up. 
  In previous literature partial recovery was described in 11 
cases [6, 9, 10], even though all reports evidenced prominent 
or pure axonal motor forms. Serum antibody studies showed, 
same as in our patients, absence of anti-GQ1b, considered 
typical of Miller Fisher Syndrome (MFS) [11]. Some reports 
suggest that GT1a could be associated with the PCB form of 
axonal GBS [7, 10, 12]. Only in one of our patients (case 2), 
we found positivity for Anti-GT1a antibodies. 
  At difference with previous reports of PCB [10] in both 
our cases the dissociation between upper and lower limb 
involvement was striking with complete strength loss in up-
per limbs after 15 days from onset. The complete sparing of 
strength and CMAPs in lower limbs, and complete sparing of 
SNAPs in upper limbs was also dramatic. 
  Our patients did not respond to i.v. IgG treatment which 
has been described to be at least partially beneficial in PCB 
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Table 1.  Electrophysiological Characteristics of Case 1 at Symptom Onset and After 15 Days 
 
Conduction Velocity 
SNAP 
Amplitude (μV)  Nerve Phase  Side  DL  (ms) 
Distal CMAP 
Amplitude (mV) 
Motor (m/s)  Sensory (m/s)   
Left 4.5  1.5  52.5  50.3  35.1  Onset 
Right 4.7  2.0  51.6 49.7 34.5 
Left -  0  -  51.2  28.8  Day 15 
Right -  0  - 53.4  31.4 
Median 
 Normal  values  3.5(0.3)  7.0(3.0)  57.7(4.9)  55.5(2.6)  38.5(15.6) 
Left 3.5  2.1  51.8  51.0  27.5  Onset 
Right 3.2  1.8  50.9 50.6 25.2 
Left -  0  -  50.4  30.1  Day 15 
Right -  0  - 49.9  28.4 
Ulnar 
 Normal  values  2.6(0.4)  5.7(2.0)  50.2(3.1)  49.2(2.4)  35.0(14.7) 
Left 13.2  5.5  49.0      Onset 
Right 12.5  4.5  50.5     
Left 13.5  4.8  48.7      Day 15 
Right 12.8  4.1  49.1     
Tibial 
 Normal  values  12.1(1.5)  5.1(2.2)  48.5(3.6)     
Left      53.5  22.8  Onset 
right      49.5  18.2 
Left      54.5  20.5  Day 15 
right      50.5  16.1 
Sural 
 Normal  values        51.1(5.9)  17.2(6.7) 
Left 7.0 0.05        Onset 
Right -  -       
Left -  0       
Phrenic 
Day 15 
Right -  0       
   Normal  values  6.5(0.8)  0.7(0.2)       
Normal values are given as mean(SD). 
 
Table 2.  Electrophysiological Characteristics of Case 2 at Symptom Onset and After 15 Days 
 
Conduction Velocity  SNAP  
Amplitude  (μV) 
Nerve Phase  Side  DL  (ms)  Distal  CMAP 
Amplitude (mV) 
Motor (m/s)  Sensory (m/s)   
Left 4.5 1.5  56.5  57.3  28.1  Onset 
Right 4.5  2.0  58.6  51.7  30.5 
Left -  0    55.2  27.8  Day 15 
Right -  0   52.5  30.4 
Median 
  Normal  values  3.5(0.3)  7.0(3.0)  57.7(4.9) 55.5(2.6) 38.5(15.6) 
Left 3.5 1.8  55.0  50.8  215  Onset 
Right 3.8  2.0  57.7  51.6  22.6 
Left -  0  0  50.4  30.1  Day 15 
Right -  0  0  49.9  28.4 
Ulnar 
  Normal  values  2.6(0.4)  5.7(2.0)  50.2(3.1) 49.2(2.4) 35.0(14.7) 4     The Open Neurology Journal, 2010, Volume 4  Bonanni et al. 
(Table 2). Contd….. 
Conduction Velocity  SNAP  
Amplitude  (μV) 
Nerve Phase  Side  DL  (ms)  Distal  CMAP 
Amplitude (mV) 
Motor (m/s)  Sensory (m/s)   
Left 13.2 5.5  48.0      Onset 
Right 12.5  4.5  48.5     
Left 13.5 4.8  48.7      Day 15 
Right 12.8  4.1  48.1     
Tibial 
 Normal  values  12.1(1.5)  5.1(2.2)  48.5(3.6)     
Left       53.5  22.8  Onset 
right       48.5  18.2 
Left       54.5  20.5  Day 15 
right       49.5  16.1 
Sural 
 Normal  values        51.1(5.9)  17.2(6.7) 
Left 7.0 0.1        Onset 
Right -  -       
Left -  0       
Phrenic 
Day 15 
Right -  0       
   Normal  values  6.5(0.8)  0.7(0.2)      
Normal values are given as mean(SD). 
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